[1]
|
卢喜烈, 杨庭树. 内科学[M]. 第9版人卫版. 上海: 上海科学技术文献出版社, 2021.
|
[2]
|
何渝娇. 91例间质性肺疾病患者临床特征及中医证候分析[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2020.
|
[3]
|
郭红敏. 不同结缔组织病肺间质病变(CTD-ILD)的临床特点及治疗效果[J]. 中国保健营养, 2016, 26(16): 136.
|
[4]
|
王妍华, 蒲丹, 罗静, 等. 147例常见结缔组织病相关间质性肺病的临床特征及转归分析[J]. 西安交通大学学报(医学版), 2019, 40(4): 598-603.
|
[5]
|
杨叶梦. IPAF与CTD-ILD临床特点[D]: [硕士学位论文]. 南昌: 南昌大学, 2017.
|
[6]
|
Travis, W.D., Costabel, U., Hansell, D.M., et al. (2013) An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine, 188, 733-748.
https://doi.org/10.1164/rccm.201308-1483ST
|
[7]
|
Cottin, V. and Brown, K.K. (2019) Interstitial Lung Disease Associated with Systemic Sclerosis (SSc-ILD). Respiratory Research, 20, Article No. 13. https://doi.org/10.1186/s12931-019-0980-7
|
[8]
|
Manfredi, A., Cassone, G., Luppi, F., et al. (2021) Rheumatoid Arthritis Related Interstitial Lung Disease. Expert Review of Clinical Immunology, 17, 485-497. https://doi.org/10.1080/1744666X.2021.1905524
|
[9]
|
敖知, 朱旭友, 郭述良, 等. 结缔组织疾病相关性间质性肺病的病理特征分析: 基于经支气管冷冻肺活检[J]. 重庆医学, 2021, 50(6): 973-976, 981.
|
[10]
|
逯明蕾. 结缔组织病相关肺间质病变的临床与基础研究[D]: [硕士学位论文]. 广州: 南方医科大学, 2011.
|
[11]
|
熊晓静. CTD-ILD患者血清学指标的临床意义[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2019.
|
[12]
|
Lud-wicka-Bradley, A., Silver, R.M. and Bogatkevich, G.S. (2011) Coagulation and Autoimmunity in Scleroderma Interstitial Lung Disease. Seminars in Arthritis and Rheumatism, 41, 212-222.
https://doi.org/10.1016/j.semarthrit.2010.10.002
|
[13]
|
Zhao, L., Su, K., Liu, T., et al. (2021) Myositis-Specific Au-toanti Bodies in Adults with Idiopathic Inflammatory Myopathy: Correlations with Diagnosis and Disease Activity. Clin-ical Rheumatology, 40, 1009-1016.
|
[14]
|
Long, K. and Danoff, S.K. (2019) Interstitial Lung Disease in Polymyositis and Dermatomyositis. Clinics in Chest Medicine, 40, 561-572. https://doi.org/10.1016/j.ccm.2019.05.004
|
[15]
|
Kelly, C.A., Saravanan, V., et al. (2014) Rheumatoid Arthritis-Related Interstitial Lung Disease: Associations, Prognostic Fac-tors and Physiological and Radiological Characteristics—A Large Multicentre UK Study. Rheumatology, 53, 1676-1682. https://doi.org/10.1093/rheumatology/keu165
|
[16]
|
苗珍珍, 殷松楼, 殷寒秋. 人血清抗MCV-Ab与类风湿关节炎合并间质性肺病的关系[J]. 河北医药, 2018, 40(14): 2095-2098.
|
[17]
|
Luppi, F., Sebastiani, M., Silva, M., Sverzellati, N., Cavazza, A., Salvarani, C. and Manfredi, A. (2020) Interstitial Lung Disease in Sjögren’s Syndrome: A Clinical Review. Clinical and Experimental Rheumatology, 126, 291-300.
|
[18]
|
Erre, G.L., Sebastiani, M., Manfredi, A., Gerratana, E., Atzeni, F., Passiu, G. and Mangoni, A.A. (2020) Antifibrotic Drugs in Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD): From Mechanistic Insights to Therapeutic Applications. Drugs in Context, 9, Arti-cle ID: 2020-8-6. https://doi.org/10.7573/dic.2020-8-6
|
[19]
|
Yoo, H., Hino, T., Han, J., Franks, T.J., Im, Y., Hata-bu, H., Chung, M.P and Lee, K.S. (2020) Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) and Interstitial Lung Abnormality (ILA): Evolving Concept of CT Findings, Pathology and Management. European Journal of Radiology Open, 8, Article ID: 100311.
https://doi.org/10.1016/j.ejro.2020.100311
|
[20]
|
Wells, A.U. (2021) New Insights into the Treatment of CTD-ILD. Nature Reviews Rheumatology, 17, 79-80.
https://doi.org/10.1038/s41584-020-00567-x
|
[21]
|
Kowal-Bielecka, O., Fransen, J., Avouac, J., et al. (2017) Update of EULAR Recommendations for the Treatment of Systemic Sclerosis. Annals of the Rheumatic Diseases, 76, 1327-1339.
https://doi.org/10.1136/annrheumdis-2016-209909
|
[22]
|
Jee, A.S. and Corte, T.J. (2019) Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD). Drugs, 79, 1511-1528. https://doi.org/10.1007/s40265-019-01178-x
|